Status | Study |
Recruiting |
Study Name: Rituximab in Eosinophilic Granulomatosis With Polyangiitis Condition: Eosinophilic Granulomatosis With Polyangiitis (EGPA) Date: 2016-05-20 Interventions: Drug: Rituximab 1 g intravenou |
Not yet recruiting |
Study Name: Immuno-ablation With Chemoimmunoradiation and Autologous Stem Cell Transplant for Churg-Strauss Syndrome Condition: Churg-Strauss Syndrome Date: 2016-03-14 Interventions: Biological: HPC cell infusion Administration of total lymp |
Recruiting |
Study Name: Maintenance of ANCA Vasculitis Remission by Intermittent Rituximab Dosing Condition: Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis Date: 2016-03-01 Interventions: Drug: Rituximab re-dosing dependent on interventional arm parameter. |
Recruiting |
Study Name: Rituximab for the Otolaryngologic Manifestations of Granulomatosis With Polyangiitis Condition: Granulomatosis With Polyangiitis (Wegener's Granulomatosis) Date: 2015-12-08 Interventions: Drug: Rituximab Standard of ca |
Recruiting |
Study Name: Vasculitis Pregnancy Registry Condition: Vasculitis Behcet's Disease CNS Vasculitis Date: 2015-10-26 Interventions: Other: Online questionnaires Women will be asked to complete questionnaires during their pregnancy and a |
Completed |
Study Name: The ANCA Vasculitis Questionnaire (AAV-PRO©) Condition: Eosinophilic Granulomatosis With Polyangiitis (Churg-Strauss) (EGPA) Churg-Strauss Syndrome Date: 2015-07-15 Interventions: Other: Online questionnaire |
Completed |
Study Name: Impact of Vasculitis on Employment and Income Condition: Vasculitis Systemic Vasculitis Behcet's Disease Date: 2015-06-12 Interventions: Other: online questionnaire The online questionnaire includes questions about vasculitis, employment and |
Recruiting |
Study Name: Pharmacokinetic Study of Rituximab Induction Regimen in ANCA-associated Vasculitis Condition: Granulomatosis, Wegener's Microscopic Polyangiitis Date: 2015-06-10 Interventions: Other: blood specimen blood specimen for serum rituximab level and serum anti-rituximab level at M1 and |
Completed |
Study Name: Residual Anti-pneumococcal Immunity After Pneumococcal Immunization in ANCA-associated Vasculitis Condition: Pneumococcal Infection ANCA-associated Vasculitis Date: 2015-05-12 |
Recruiting |
Study Name: Immunogenicity of a Combined Anti-pneumococcal Vaccine Schedule in Patients With ANCA-associated Vasculitis Condition: Pneumococcal Infection ANCA-associated Vasculitis Date: 2015-05-12 |